Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors.
After intravenous administration, adenovirus (Ad) vectors are predominantly sequestered by the liver. Delineating the mechanisms for Ad accumulation in the liver is crucial for a better understanding of Ad clearance and Ad-associated innate toxicity. To help address these issues, in this study, we used Ad vectors with different fiber shaft lengths and either coxsackievirus-Ad receptor (CAR)-interacting Ad serotype 9 (Ad9) or non-CAR-interacting Ad35 fiber knob domains. We analyzed the kinetics of Ad vector accumulation in the liver, uptake into hepatocytes and Kupffer cells, and induction of cytokine expression and release in response to systemic vector application. Immediately after intravenous injection, all Ad vectors accumulated equally efficiently in the liver; however, only genomes of long-shafted Ads were maintained in the liver tissue over time. We found that Kupffer cell uptake of long-shafted Ads was mediated by the fiber knob domain and was CAR independent. The short-shafted Ads were unable to efficiently interact with hepatocellular receptors and were not taken up by Kupffer cells. Moreover, our studies indicated that Kupffer cells were not the major reservoir for the observed accumulation of Ads (used in this study) in the liver within the first 30 min after virus infusion. The lower level of liver cell transduction by short-shafted Ads correlated with a significantly reduced inflammatory anti-Ad response as well as liver damage induced by the systemic administration of these vectors. This study contributes to a better understanding of the biology of systemically applied Ad and will help in designing safer vectors that can efficiently transduce target tissues.
Shayakhmetov
Dmitry M
DM
Division of Medical Genetics, University of Washington, Seattle, WA 98195, USA.
Li
Zong-Yi
ZY
Ni
Shaoheng
S
Lieber
André
A
D000256:Adenoviridae / Q000235:genetics* / Q000472:pathogenicity; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D016207:Cytokines / Q000235:genetics; D005822:Genetic Vectors / Q000235:genetics / Q000633:toxicity*; D022781:Hepatocytes / Q000821:virology*; D015850:Interleukin-6 / Q000097:blood; D007728:Kupffer Cells / Q000821:virology; D008099:Liver / Q000821:virology*; D051379:Mice; D008810:Mice, Inbred C57BL; D011991:Receptors, Virus / Q000502:physiology; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D016207:Cytokines; D015850:Interleukin-6; D011991:Receptors, Virus; D014409:Tumor Necrosis Factor-alpha; D000410:Alanine Transaminase